Research Article
No access
Published Online: 10 October 2019

Efficient Screening and Design of Variable Domain of Heavy Chain Antibody Ligands Through High Throughput Sequencing for Affinity Chromatography to Purify Fab Fragments

Publication: Monoclonal Antibodies in Immunodiagnosis and Immunotherapy
Volume 38, Issue Number 5

Abstract

To design an affinity ligand for purification of antigen-binding fragment (Fab) antibody, variable domain of heavy chain antibody (VHH) phage libraries were constructed from Fab-immunized Alpaca and subjected to biopanning against Fabs. To find the specific binders, we directly applied high-throughput sequencing (HTS) analysis of the VHH sequences in the panned phages on next-generation sequencer. The efficiently enriched sequences were aligned for construction of the phylogenetic tree to be categorized into five groups. VHHs from three major groups were first selected to analyze their properties as an affinity ligand. However, those VHHs were not suitable as an affinity ligand because of lack of resistance against alkaline pH and/or difficulty in acidic elution from the affinity column. So, we further searched the candidates from minor group sequences. Among five, one VHH showed the binding ability but with low affinity against Fabs. Therefore, we improved its affinity-by-affinity maturation through error-prone PCR library techniques. The final designed VHH showed highly alkaline pH resistance and easy acidic elution together with high affinity to Fabs. These results indicate that HTS techniques combined with biopanning and followed by error-prone PCR library techniques is powerful in designing specific binders with desired properties.

Get full access to this article

View all available purchase options and get full access to this article.

References

1. Ecker DM, Jones SD, and Levine HL: The therapeutic monoclonal antibody market. mAbs 2015;7:9–14.
2. Chames P, Van Regenmortel M, Weiss E, and Baty D: Therapeutic antibodies: Successes, limitations and hopes for the future. Br J Pharmacol 2009;157:220–233.
3. Choi DK, Bae J, Shin SM, Shin JY, Kim S, and Kim YS: A general strategy for generating intact, full-length IgG antibodies that penetrate into the cytosol of living cells. mAbs 2014;6:1402–1414.
4. Holliger P, and Hudson PJ: Engineered antibody fragments and the rise of single domains. Nat Biotechnol 2005;23:1126–1136.
5. Fitting J, Blume T, Ten HA, Blau W, Gattenlöhner S, Tur MK, and Barth S: Phage display-based generation of novel internalizing antibody fragments for immunotoxin-based treatment of acute myeloid leukemia. mAbs 2015;7:390–402.
6. Kholodenko RV, Kalinovsky DV, Doronin II, Ponomarev ED, and Kholodenko IV: Antibody Fragments as Potential Biopharmaceuticals for Cancer Therapy: Success and Limitations. Curr Med Chem 2019;26:396–426.
7. Scheffer GL, Reurs AW, Jutten B, Beiboer SHW, Van Amerongen R, Schoester M, Wiemer EAC, Hoogenboom HR, and Scheper RJ: Selection and characterisation of a phage-displayed human antibody (Fab) reactive to the lung resistance-related major vault protein. Br J Cancer 2002;86:954–962.
8. Parren PWHI, and Lugovskoy AA: Therapeutic Antibody Engineering: Current and Future Advances Driving the Strongest Growth Area in the Pharmaceutical Industry. mAbs 2013;5:175–177.
9. Nelson AL: Antibody fragments: Hope and hype. mAbs 2010;2:77–83.
10. Reichert JM: Marketed therapeutic antibodies compendium. mAbs 2012;4:413–415.
11. Nelson AL, and Reichert JM: Development trends for therapeutic antibody fragments. Nat Biotechnol 2009;27:331–337.
12. Björck L: Protein L: A novel bacterial cell wall protein with affinity for Ig L chains. J Immunol 1988;140:1194–1197.
13. Willems A, Leoen J, Schoonooghe S, Grooten J, and Mertens N: Optimizing expression and purification from cell culture medium of trispecific recombinant antibody derivatives. J Chromatogr BAnalyt Technol Biomed Life Sci 2003;786:161–176.
14. De Chateau M, Nilson BH, Erntell M, Myhre E, Magnusson CG, Akerstrom B, and Bjorck L: On the Interaction between Protein L and immunoglobulins of various mammalian species. Scand J Immunol 1993;37:399–405.
15. Scanlan C: Downstream Purification and formulation of Fab antibody fragments. BioPharm Int 2014;27:502–520.
16. Eifler N, Medaglia G, Anderka O, Laurin L, and Hermans P: Development of a novel affinity chromatography resin for platform purification of lambda fabs. Biotechnol Prog 2014;30:1311–1318.
17. Rodrigo G, and Grönlund S: Platform approaches for the purification of antibody fragments. BioProcess Int 2012 [Epub ahead of print];.
18. Hage DS: Affinity chromatography: A review of clinical applications. Clin Chem 1999;45:593–615.
19. Urh M, Simpson D, and Zhao K: Affinity Chromatography. General Methods. Methods Enzymol 2009;463:417–438.
20. Hamers-Casterman C, Atarhouch T, Muyldermans S, Robinson G, Hammers C, Bajyana EB, Bendahman N, and Hammers R: Naturally occurring antibodies devoid of light chains. Nature 1993;363:446–448.
21. Muyldermans S: Nanobodies: Natural Single-Domain Antibodies. Annu Rev Biochem 2013;82:775–797.
22. Harmsen MM, and De Haard HJ: Properties, production, and applications of camelid single-domain antibody fragments. Appl Microbiol Biotechnol 2007;77:13–22.
23. Dumoulin M, Conrath K, Van Meirhaeghe A, Meersman F, Heremans K, Frenken LG, Muyldermans S, Wyns L, and Matagne A: Single-domain antibody fragments with high conformational stability. Protein Sci 2002;11:500–515.
24. Arbabi Ghahroudi M, Desmyter A, Wyns L, Hamers R, and Muyldermans S: Selection and identification of single domain antibody fragments from camel heavy-chain antibodies. FEBS Lett 1997;414:521–526.
25. Pérez JMJ, Renisio JG, Prompers JJ, Van Platerink CJ, Cambillau C, Darbon H, and Frenken LGJ: Thermal unfolding of a llama antibody fragment: A two-state reversible process. Biochemistry 2001;40:74–83.
26. Ladenson RC, Crimmins DL, Landt Y, and Ladenson JH: Isolation and characterization of a thermally stable recombinant anti-caffeine heavy-chain antibody fragment. Anal Chem 2006;78:4501–4508.
27. Omidfar K, Rasaee MJ, Kashanian S, Paknejad M, and Bathaie Z: Studies of thermostability in Camelus bactrianus (Bactrian camel) single-domain antibody specific for the mutant epidermal-growth-factor receptor expressed by Pichia. Biotechnol Appl Biochem 2007;46:41–49.
28. Ewert S, Cambillau C, Conrath K, and Plückthun A: Biophysical properties of camelid V HH domains compared to those of human V H 3 domains. Biochemistry 2002;41:3628–3636.
29. Arbabi-Ghahroudi M, Tanha J, and MacKenzie R: Prokaryotic expression of antibodies. Cancer Metastasis Rev 2005;24:501–519.
30. Tanha J, Nguyen TD, Ng A, Ryan S, Ni F, and MacKenzie R: Improving solubility and refolding efficiency of human VHs by a novel mutational approach. Protein Eng Des Sel 2006;19:503–509.
31. Frenken LGJ, Van Der Linden RHJ, Hermans PWJJ, Bos JW, Ruuls RC, De Geus B, and Verrips CT: Isolation of antigen specific Llama V(HH) antibody fragments and their high level secretion by Saccharomyces cerevisiae. J Biotechnol 2000;78:11–21.
32. Griffiths AD, Williams SC, Hartley O, Tomlinson IM, Waterhouse P, Crosby WL, Kontermann RE, Jones PT, Low NM, and Allison TJ: Isolation of high affinity human antibodies directly from large synthetic repertoires. EMBO J 1994;13:3245–3260.
33. Muraoka S, Ito Y, Kamimura M, Baba M, Arima N, Suda Y, Hashiguchi S, Torikai M, Nakashima T, and Sugimura K: Effective induction of cell death on adult T-cell leukaemia cells by HLA-DRβ-specific small antibody fragment isolated from human antibody phage library. J Biochem 2009;145:799–810.
34. Dekosky BJ, Ippolito GC, Deschner RP, Lavinder JJ, Wine Y, Rawlings BM, Varadarajan N, Giesecke C, Dörner T, Andrews SF, Wilson PC, Hunicke-Smith SP, Willson CG, Ellington AD, and Georgiou G: High-throughput sequencing of the paired human immunoglobulin heavy and light chain repertoire. Nat Biotechnol 2013;31:166–169.
35. Reddy ST, Ge X, Miklos AE, Hughes RA, Kang SH, Hoi KH, Chrysostomou C, Hunicke-Smith SP, Iverson BL, Tucker PW, Ellington AD, and Georgiou G: Monoclonal antibodies isolated without screening by analyzing the variable-gene repertoire of plasma cells. Nat Biotechnol 2010;28:965–969.
36. Zhu J, Ofek G, Yang Y, Zhang B, Louder MK, Lu G, McKee K, Pancera M, Skinner J, Zhang Z, Parks R, Eudailey J, Lloyd KE, Blinn J, Alam SM, Haynes BF, Simek M, Burton DR, Koff WC, Mullikin JC, Mascola JR, Shapiro L, and Kwong PD: Mining the antibodyome for HIV-1-neutralizing antibodies with next-generation sequencing and phylogenetic pairing of heavy/light chains. Proc Natl Acad Sci USA 2013;110:6470–6475.
37. Clark LA, Boriack-Sjodin PA, Eldredge J, Fitch C, Friedman B, Hanf KJM, Jarpe M, Liparoto SF, Li Y, Lugovskoy A, Miller S, Rushe M, Sherman W, Simon K, and Van Vlijmen H: Affinity enhancement of an in vivo matured therapeutic antibody using structure-based computational design. Protein Sci 2006;15:949–960.
38. Antikainen NM, and Martin SF: Altering protein specificity: Techniques and applications. Bioorg Med Chem 2005;13:2701–2716.
39. Biles BD, and Connolly BA: Low-fidelity Pyrococcus furiosus DNA polymerase mutants useful in error-prone PCR. Nucleic Acids Res 2004;32:e176.
40. Miyazaki N, Kiyose N, Akazawa Y, Takashima M, Hagihara Y, Inoue N, Matsuda T, Ogawa R, Inoue S, and Ito Y: Isolation and characterization of antigen-specific alpaca (Lama pacos) VHH antibodies by biopanning followed by high-Throughput sequencing. J Biochem 2015;158:205–215.
41. Sambrook J, and Russell DW: Purification of Nucleic Acids by Extraction with Phenol:Chloroform. Cold Spring Harb Protoc 2006;2006: pii:
42. Quan S, Hiniker A, Collet JF, and Bardwell JCA: Isolation of bacteria envelope proteins. Methods Mol Biol 2013;966:359–366.
43. Trivedi M, Laurence J, and Siahaan T: The Role of Thiols and Disulfides on Protein Stability. Curr Protein Pept Sci 2009;10:614–625.
44. Douzi B: Protein–protein interactions: Surface plasmon resonance. Methods Mol Biol 2017;1615:257–275.
45. Malo N, Hanley JA, Cerquozzi S, Pelletier J, and Nadon R: Statistical practice in high-throughput screening data analysis. Nat Biotechnol 2006;24:167–175.
46. Magdeldin S, and Moser A: Affinity Chromatography: Principles and Applications. Affinity Chromatography 2012. [Epub ahead of print];.
47. Hale G, Drumm A, Harrison P, and Phillips J: Repeated cleaning of protein A affinity column with sodium hydroxide. J Immunol Methods 1994;17:15–21.

Information & Authors

Information

Published In

cover image Monoclonal Antibodies in Immunodiagnosis and Immunotherapy
Monoclonal Antibodies in Immunodiagnosis and Immunotherapy
Volume 38Issue Number 5October 2019
Pages: 190 - 200
PubMed: 31411543

History

Published online: 10 October 2019
Published in print: October 2019
Published ahead of print: 14 August 2019
Accepted: 11 July 2019
Received: 19 June 2019

Permissions

Request permissions for this article.

Topics

Authors

Affiliations

Abdur Rafique
Department of Chemistry and Bioscience, Graduate School of Science and Engineering, University of Kagoshima, Kagoshima, Japan.
Kiriko Satake
Department of Chemistry and Bioscience, Graduate School of Science and Engineering, University of Kagoshima, Kagoshima, Japan.
Satoshi Kishimoto
Department of Chemistry and Bioscience, Graduate School of Science and Engineering, University of Kagoshima, Kagoshima, Japan.
Kamrul Hasan Khan
Department of Chemistry and Bioscience, Graduate School of Science and Engineering, University of Kagoshima, Kagoshima, Japan.
Dai-ichiro Kato
Department of Chemistry and Bioscience, Graduate School of Science and Engineering, University of Kagoshima, Kagoshima, Japan.
Department of Chemistry and Bioscience, Graduate School of Science and Engineering, University of Kagoshima, Kagoshima, Japan.

Notes

Address correspondence to: Yuji Ito, Department of Chemistry and Bioscience, Graduate School of Science and Engineering, University of Kagoshima, Kagoshima 890-0065, Japan [email protected]

Author Disclosure Statement

No competing financial interests exist.

Metrics & Citations

Metrics

Citations

Export citation

Select the format you want to export the citations of this publication.

View Options

Get Access

Access content

To read the fulltext, please use one of the options below to sign in or purchase access.

Society Access

If you are a member of a society that has access to this content please log in via your society website and then return to this publication.

Restore your content access

Enter your email address to restore your content access:

Note: This functionality works only for purchases done as a guest. If you already have an account, log in to access the content to which you are entitled.

View options

PDF/EPUB

View PDF/ePub

Full Text

View Full Text

Media

Figures

Other

Tables

Share

Share

Copy the content Link

Share on social media

Back to Top